| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.1M | +1227.6% |
| R&D Expense | $900K | +0.0% |
| SG&A Expense | $65.1M | +36.9% |
| Operating Income | -$644.1M | -527.2% |
| Pre-tax Income | -$659.8M | -344.6% |
| Income Tax | $298K | +183.7% |
| Net Income | -$660.0M | -342.2% |
| EPS (Basic) | -$2.91 | -212.9% |
| EPS (Diluted) | -$2.91 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.3M | +387.3% |
| Accounts Receivable | $667K | +88.4% |
| Current Assets | $275.7M | +244.1% |
| Total Assets | $292.7M | +83.7% |
| Current Liabilities | $23.5M | -5.9% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $70.7M | +65.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$102.7M | -24.5% |
| Capital Expenditures | $901K | — |
| Investing Cash Flow | -$109.1M | -284.4% |
| Financing Cash Flow | $269.5M | +4914.5% |
| Free Cash Flow | -$103.6M | -25.6% |
| -212.9% |
| Stockholders' Equity |
| $221.9M |
| +90.8% |